Announced Fri, 15 May · 19:33 IST

Jupiter Life Line Hospitals Limited has informed the Exchange regarding Appointment of Dr.. Tushar Patil as Head Operations- Dombivli of the company w.e.f. May 15, 2026.

Management Changes View source PDF

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.2%1-day move
₹1323.00
prior close
₹1335.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-2.2-2.6-2.9+1.2-0.2-1.2+2.7+2.6+0.2+1.5+1.9+17.8
Up moveDown movePending
AI summary

Jupiter Life Line Hospitals Limited held a board meeting on May 15, 2026 and approved multiple items. Financially, the company reported audited consolidated net profit of ₹1,941.87 million for FY2026 (vs ₹1,937.54 million in FY2025), with total consolidated revenue of ₹15,421.55 million. An interim dividend of 10% (₹1 per share) was declared with record date May 22, 2026. A stock split was approved converting every 1 share of ₹10 face value into 5 shares of ₹2 each, effectively increasing liquidity and making the stock more affordable. Dr. Ajay Thakker was elevated to Chairman & Whole Time Director, and Dr. Tushar Patil (Head Operations, Dombivli) was appointed as Senior Managerial Personnel. The company also appointed Varma & Varma as Internal Auditor and M/s V.J. Talati & Co. as Cost Auditor for FY2026-27.

Likely market impact

The stock split enhances affordability and accessibility for retail investors, while the consistent profit growth and dividend declaration signal financial stability. The senior management appointments and governance changes indicate a structured leadership transition.